Cargando…
Correction to “Rapamycin Inhibits Osteoclastogenesis and Prevents LPS-Induced Alveolar Bone Loss by Oxidative Stress Suppression”
Autores principales: | Feng, Chong, Liu, Yan, Zhang, Bao-Yi, Zhang, Hao, Shan, Fa-Yu, Li, Tian-Qi, Zhao, Zhi-Ning, Wang, Xin-Xing, Zhang, Xiang-Yu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10634290/ https://www.ncbi.nlm.nih.gov/pubmed/37969978 http://dx.doi.org/10.1021/acsomega.3c07440 |
Ejemplares similares
-
Rapamycin Inhibits
Osteoclastogenesis and Prevents
LPS-Induced Alveolar Bone Loss by Oxidative Stress Suppression
por: Feng, Chong, et al.
Publicado: (2023) -
Ulinastatin Inhibits Osteoclastogenesis and Suppresses Ovariectomy-Induced Bone Loss by Downregulating uPAR
por: Huang, Jun-ming, et al.
Publicado: (2018) -
Effects of O‐methylated (−)‐epigallocatechin gallate (EGCG) on LPS‐induced osteoclastogenesis, bone resorption, and alveolar bone loss in mice
por: Tominari, Tsukasa, et al.
Publicado: (2017) -
Corrigendum: Ulinastatin Inhibits Osteoclastogenesis and Suppresses Ovariectomy-Induced Bone Loss by Downregulating uPAR
por: Huang, Jun-ming, et al.
Publicado: (2018) -
Artemether attenuates LPS-induced inflammatory bone loss by inhibiting osteoclastogenesis and bone resorption via suppression of MAPK signaling pathway
por: Wu, Haobo, et al.
Publicado: (2018)